Sacramento Bee6d
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
Non-Habit Forming: Unlike Pregabalin, Ketamir-2 carries no known risk of dependence, making it safer for long-term use. Fewer ...
greenmarketreport5d
MIRA says ketamine-based drug beats current pain treatments in study
The firm says it could offer an alternative to existing treatments while sidestepping addiction concerns that have plagued ...
Medscape2d
Pregabalin: An Antiepileptic Agent Useful for Neuropathic Pain
Although pregabalin is mechanistically similar to gabapentin and shares similar advantages, such as a lack of pharmacokinetic interactions with other medications or enzyme induction, there are ...
Journal.ie on MSN15d
Medical Council suggests controls needed on widely used prescription drug
A WORKING GROUP of health experts led by the Medical Council has told the government it should consider reclassifying a ...
MIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatments
MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...
Medscape2d
Trazodone Plus Pregabalin Combination in the Treatment of Fibromyalgia
[14] The main objective of the present study was to evaluate whether pregabalin augmentation additionally improved fibromyalgia symptomatology. A secondary objective was to assess the efficacy and ...
Kansas City Star6d
MIRA Pharmaceuticals Announces Ketamir-2 Outperforms Current FDA-Approved Neuropathic Pain Treatments, Gabapentin and Pregabalin, in Preclinical Study
Non-Habit Forming: Unlike Pregabalin, Ketamir-2 carries no known risk of dependence, making it safer for long-term use. Fewer Cognitive Side Effects: With the potential to avoid sedation and ...